Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-08-23 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper publication about a 100 days campaign called "Saksham Niveshak" aimed at facilitating dividend claims, KYC updates, and preventing transfer of unpaid/unclaimed dividends to the Investor Education and Protection Fund Authority (IEPFA). It includes copies of newspaper advertisements and detailed instructions for shareholders to update their KYC and claim dividends. The document is a formal announcement of this campaign and related shareholder information, not a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is also not a proxy statement, voting results, or a regulatory filing of a different nature. The document is informational and regulatory in nature, fulfilling disclosure obligations under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure.
2025-08-23 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) dated 14th August 2025. It announces changes in senior management personnel, specifically the cessation of Ms. Surabhi Kaul as a Senior Management Personnel and the appointment of Ms. Richa Bakshi as the People Excellence Lead (Senior Management Personnel). The letter references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in senior management. The content includes detailed information about the personnel changes, dates, and brief profiles, consistent with a management change announcement. There is no financial data, earnings information, or report publication mentioned. The document is not a report but an announcement of management changes. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-08-14 English
Intimation is enclosed.
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) dated 14th August 2025. It announces changes in senior management personnel of Sanofi India Limited, specifically the cessation of Ms. Surabhi Kaul as a Senior Management Personnel and the appointment of Ms. Richa Bakshi as People Excellence Lead (Senior Management Personnel). The letter references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events including management changes. The content includes detailed information about the personnel changes, dates, and brief profiles, consistent with a management change announcement. There is no financial data, earnings information, or report publication mentioned. The document is not a report but an announcement of management changes. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (5326 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-08-14 English
Cessation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding changes in senior management personnel of Sanofi India Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including management changes. The content details the cessation of one senior management person and the appointment of another, including dates and brief profiles. There is no financial data, earnings information, or report publication mentioned. The document is clearly an announcement of management changes, fitting the category of Board/Management Information (MANG). The document length (5326 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-08-14 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains multiple distinct sections. The first part is a letter dated 13th August 2025 from the company secretary of Sanofi India Limited addressed to stock exchanges regarding the newspaper publication of a Notice of Postal Ballot for appointment of directors. This is an announcement of a notice related to shareholder voting, not the voting results themselves. The second part is a press release titled 'Extracts of the Unaudited Financials results for the period ended June 30, 2025' for Varthana Finance Private Limited, which includes unaudited quarterly financial data and is clearly a quarterly financial report. The document also contains other unrelated text, including cultural and local news content, which is irrelevant to classification. Given the presence of unaudited quarterly financial results with substantive financial data and analysis, the document fits the definition of an Interim / Quarterly Report (IR). The letter about the postal ballot notice is an announcement but is not the main content of the document. The main financial content is the quarterly financial results extract, which is substantive and detailed, thus qualifying as an IR filing. Therefore, the correct classification is IR with high confidence. Q1 2025
2025-08-13 English
Newspaper Publication enclosed
Interim / Quarterly Report Classification · 95% confidence The document contains multiple distinct sections. The first part is a letter dated 13th August 2025 from the company secretary of Sanofi India Limited addressed to stock exchanges regarding the newspaper publication of a Notice of Postal Ballot for appointment of directors. This is an announcement of a notice related to shareholder voting, not the voting results themselves. The second part is a press release titled 'Extracts of the Unaudited Financials results for the period ended June 30, 2025' for Varthana Finance Private Limited, which includes unaudited quarterly financial data and is filed under Regulation 52 of SEBI LODR Regulations. This is a quarterly financial results announcement with substantive financial data. The document also contains other unrelated text in Marathi, which appears to be news or cultural content, not related to financial filings. Given the presence of unaudited quarterly financial results with detailed financial data, the document fits best as an Interim / Quarterly Report (IR). The initial letter about the postal ballot notice is an announcement but is overshadowed by the substantive financial data in the quarterly results. Therefore, the classification is IR with high confidence. Q1 2025
2025-08-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.